Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: monoclonal T cell receptor therapeutics - MediGene Ltd

Drug Profile

Research programme: monoclonal T cell receptor therapeutics - MediGene Ltd

Alternative Names: Monoclonal TCRs; mTCRs; SurDex; TaxoDex

Latest Information Update: 15 Dec 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Avidex
  • Developer MediGene Ltd
  • Class Monoclonal antibodies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; Immunomodulators; Immunostimulants; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Autoimmune disorders; Leukaemia
  • Discontinued Bladder cancer; Lung cancer; Pancreatic cancer; Prostate cancer; Viral infections

Most Recent Events

  • 15 Dec 2015 Preclinical trials in Autoimmune disorders in United Kingdom (unspecified route) before December 2015
  • 15 Dec 2015 Preclinical trials in Leukaemia in United Kingdom (unspecified route)
  • 17 Jan 2007 Preclinical development is ongoing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top